Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study-Reference-Cited by-同舟云学术

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

Published:2017-12 Issue:12 Volume:2 Page:869-876
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Weiss Karl Heinz,Askari Frederick K,Czlonkowska Anna,Ferenci Peter,Bronstein Jeff M,Bega Danny,Ala Aftab,Nicholl David,Flint Susan,Olsson Lars,Plitz Thomas,Bjartmar Carl,Schilsky Michael L

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Diagnosis and treatment of Wilson disease: an update;Roberts;Hepatology,2008

2. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing;Ferenci;Hum Genet,2006

3. A genetic study of Wilson's disease in the United Kingdom;Coffey;Brain,2013

4. Wilson's disease and other neurological copper disorders;Bandmann;Lancet Neurol,2015

5. Wilson's disease in patients presenting with liver disease: a diagnostic challenge;Steindl;Gastroenterology,1997

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Superoxide signal orchestrates tetrathiomolybdate-induced longevity via ARGK-1 in Caenorhabditis elegans;Free Radical Biology and Medicine;2024-09

2. Acute insomnia as the initial manifestation of Wilson’ s disease: A Case Report;Medicine;2024-08-16

3. Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases;Apoptosis;2024-07-16

4. Superoxide is an Intrinsic Signaling Molecule Triggering Muscle Hypertrophy;Antioxidants & Redox Signaling;2024-07-12

5. Liver transplantation for Wilson disease: Current knowledge and future perspectives;Liver Transplantation;2024-06-19